Ruxolitinib as a promising treatment for corticosteroid-refractory graft-versus-host disease

Br J Haematol. 2018 Jun;181(5):687-689. doi: 10.1111/bjh.14679. Epub 2017 Apr 25.
No abstract available

Keywords: corticosteroids; graft-versus-host disease; hematopoietic stem cell transplantation; malignant haematology; ruxolitinib.

Publication types

  • Letter

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Adult
  • Aged
  • Allografts
  • Female
  • Graft vs Host Disease / drug therapy*
  • Graft vs Host Disease / etiology
  • Hematologic Neoplasms / therapy*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Male
  • Middle Aged
  • Nitriles
  • Pyrazoles / administration & dosage*
  • Pyrimidines
  • Retrospective Studies

Substances

  • Adrenal Cortex Hormones
  • Nitriles
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib